Bin Lu,
Liu, Hui
Tabor, David E.
Tovchigrechko, Andrey
Qi, Yanping
Ruzin, Alexey
Esser, Mark T.
Jin, Hong
Article History
Received: 11 November 2018
Accepted: 11 February 2019
First Online: 7 March 2019
Competing Interests
: All authors are employees of MedImmune/AstraZeneca and are the share holders of AstraZeneca. This does not alter our adherence to Scientific Reports’ policies on sharing data and materials. Medimmune/AstraZeneca had no direct roles in study design, data collection, analysis, and manuscript preparation.